AG Ventures Q4 FY24 Share Price & Earnings Call Analysis

₹129.20+5.17% today
Market cap
₹128 Cr
P/E
5.65
ROE
1.85%
PEG
-0.12
Price to sales
0.96
Debt to equity
0.11
52W high / low
₹166 / ₹74.7
Sales growth (5Y)
-22.45%
EBITDA margin
22.75%
Net profit margin
6.82%
Promoter holding
51.76%
Sales (last year)
₹135 Cr

Incorporated in 1978, A G Ventures Ltd is in the business of Investments and Trading.[1]

Guidance scorecard · Q4 FY24 call

What AG Ventures Ltd's management guided
and where it ranks in Chemicals & Petrochemicals

RevenueQ4 FY24 call

0–10%
  • The company expects global insoluble sulphur demand growth of around 3-4% annually.
  • Domestic demand growth is anticipated to be higher, around 8-10%, driven by the Indian market.
  • Plans to expand market footprint both geographically and by targeting global manufacturers.
  • Growth expected to outpace overall global market growth due to opportunities in untapped geographies and manufacturers.
  • Phase-2 capacity expansion will be considered once utilization exceeds 85-90%.
  • Revenue growth observed: FY24 total income was Rs. 401 crores, a 14% year-on-year increase.
  • Volume growth has contributed to recent performance improvements.

2 more points from AG Ventures Ltd's call on revenue

Create a free account to keep reading this call

Full Q4 FY24 analysis

MarginsQ4 FY24 call

Down 0–2%

See what AG Ventures Ltd said on margins — free account, 30 seconds.

Full Q4 FY24 analysis

CapexQ4 FY24 call

None planned
  • Current CAPEX is restricted mainly to maintenance and payback investments.
  • No immediate plans for major capacity expansions; Phase-2 expansion will be considered only when utilization exceeds 85-90%.
  • The company continues to deploy capital year-on-year in private equity and venture investments, seeking good opportunities.
  • Debt repayments have been prioritized, with a healthy balance sheet maintained.

2 more points from AG Ventures Ltd's call on capex

Create a free account to keep reading this call

Full Q4 FY24 analysis

FundraisingQ4 FY24 call

None planned

See what AG Ventures Ltd said on fundraising — free account, 30 seconds.

Full Q4 FY24 analysis

Order bookQ4 FY24 call

  • It is noted that the company is experiencing volume growth and increased sales in certain quarters.
  • There is mention of market challenges, especially in North America and Europe, which impact order levels and penetration.
  • The company expects growth above the global average due to higher domestic market demand (8-10%).
  • Management highlighted that demand in Europe is stabilized but subdued; North American market penetration is ongoing but slower due to domestic competition.

2 more points from AG Ventures Ltd's call on the order book

Create a free account to keep reading this call

Full Q4 FY24 analysis

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. 2
  2. Strong growth
    1
  3. Strong growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹263 Cr3.4
240%+Flat₹4,375 Cr83.7
340%+Flat₹3,259 Cr4.0
440%+Flat₹145 Cr15.9
520–40%Up 2%+₹1.81L Cr90.9
620–40%Up 2%+₹48,366 Cr78.3

Financials of AG Ventures Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of AG Ventures Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +122.2919.1520.0518.2023.4118.6832.1129.6527.8320.9029.9531.1425.22
Expenses +94.2614.7315.3614.9617.3517.0127.0825.8125.2518.1628.3728.6424.29
Operating Profit28.034.424.693.246.061.675.033.842.582.741.582.500.93
OPM %22.92%23.08%23.39%17.80%25.89%8.94%15.66%12.95%9.27%13.11%5.28%8.03%3.69%
Other Income +0.2914.347.945.3712.007.780.730.640.790.640.941.350.91
Interest3.090.030.040.020.020.010.100.120.500.070.190.580.62
Depreciation7.200.790.800.810.800.840.961.061.051.051.061.001.00
Profit before tax18.0317.9411.797.7817.248.604.703.301.822.261.272.270.22
Tax %23.96%3.57%7.72%9.77%3.71%7.79%69.57%33.33%17.03%-67.26%28.35%0.88%-154.55%
Net Profit +13.7217.3010.877.0216.607.931.442.201.513.790.902.240.56
EPS in Rs12.6316.2910.076.7915.607.540.201.850.883.170.201.73-0.03

Financials of AG Ventures Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +34730733236943238738444453782109107
Expenses +277228245266304282257356425639599
Operating Profit6979861031281051278811119148
OPM %20%26%26%28%30%27%33%20%21%24%13%7%
Other Income +12464692723994
Interest108799107813011
Depreciation161717182021222429344
Profit before tax5559698010683100637055186
Tax %18%22%30%29%28%9%17%27%24%3%29%-24%
Net Profit +45464857777583465453138
EPS in Rs46.8848.0849.7455.1775.1373.1479.0043.0748.6449.4810.475.07
Dividend Payout %18%18%20%18%16%14%18%32%29%28%0%0%

Financials of AG Ventures Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital101010101010101010101010
Reserves234273326371399455523551592627256261
Borrowings +107861111221321541851891671329
Other Liabilities +888279859178961151172575757
Total Liabilities439451527589631697814865886896327357
Fixed Assets +2152073273283613543424534787069129
CWIP440340325113411000
Investments2716386193133185181225246221185
Other Assets +1931891591601741851731901815803742
Total Assets439451527589631697814865886896327357

Financials of AG Ventures Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +70708294931159161105978-6
Cash from Investing Activity +-31-40-82-74-49-85-129-41-54-4312-20
Cash from Financing Activity +-34-38-2-12-50-1016-21-52-54-1824
Net Cash Flow5-9-28-620-21-0-111-2
Free Cash Flow52171332716781183785-70
CFO/OP118%107%112%107%89%125%84%82%103%566%105%-44%

Financials of AG Ventures Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days717293807567777155351939
Inventory Days14919716216915213416214111912812687
Days Payable837794916361866544695849
Cash Conversion Cycle137193160158165140153147130938777
Working Capital Days1921443242338584741,52625207
ROCE %19%18%18%18%22%15%16%9%11%-3%1%2%

Guidance history

How AG Ventures Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q4 FY24 call →0–10%Down 0–2%None plannedNone planned—
Q3 FY24 call →0–10%FlatNone plannedNone planned—
Q2 FY24 call →0–10%FlatPlanned——

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

Others in Chemicals & Petrochemicals this season

  • Neogen Chemicals Ltd (Q2 FY27)

    Consolidated: ₹295.96 crore (up from ₹208.66 crore in Q3 FY25) . Key results statement takeaways from Neogen Chemicals Ltd's Q2 FY27 results statement — and how

  • Mahickra Chemicals Ltd (Q2 FY27)

    682 million, a 34% year-on-year increase. Key results statement takeaways from Mahickra Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec

  • Vishnu Chemicals Ltd (Q2 FY27)

    2,837.7 lakhs increase (~7.07% growth YoY). Key results statement takeaways from Vishnu Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec

  • Yasons Chemex (Q2 FY27)

    4,927.35 lakhs for the same period in 2025, indicating a year-on-year decline of about 16.3% (Page 12). Key results statement takeaways from Yasons Chemex Care